Fresenius Medical Care (FMS) to Release Earnings on Tuesday

Fresenius Medical Care (NYSE:FMS) is expected to release its Q1 2025 earnings data before the market opens on Tuesday, May 6th. Analysts expect Fresenius Medical Care to post earnings of $0.45 per share and revenue of $4.71 billion for the quarter.

Fresenius Medical Care Trading Up 2.4 %

Shares of NYSE FMS opened at $25.05 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The business’s 50 day moving average price is $23.99 and its 200-day moving average price is $23.07. The company has a market cap of $14.70 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 0.76 and a beta of 0.93. Fresenius Medical Care has a fifty-two week low of $17.93 and a fifty-two week high of $25.96.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on FMS shares. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Truist Financial boosted their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Monday, January 6th.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.